1. |
李德新, 贾慧敏, 王清涛. BNP的测定和临床应用的研究进展. 现代生物医学进展, 2006, 6(10): 139-142.
|
2. |
Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature, 1988, 332(6159): 78-81.
|
3. |
苏哲坦. 脑钠利尿肽临床应用的进展及其争论. 海南医学院学报, 2005, 11(5): 438-441.
|
4. |
谷国强. 急性肺栓塞患者危险分层的生物学指标. 国际心血管病杂志, 2006, 33(2): 110-113.
|
5. |
Cavallazzi R, Nair A, Vasu T, et al. Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med, 2008, 34(12): 2147-56.
|
6. |
Coutance G, Le Page O, Lo T, et al. Prognostic value of brain natriuretic peptide in acute pulmonary embolism. Crit Care, 2008, 12(4): R109. Epub 2008 Aug 22.
|
7. |
Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation, 2003, 107: 2545-2547.
|
8. |
Ten Wolde M, Tulevski II, Mulder JW. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation, 2003, 107: 2082-2084.
|
9. |
Pieralli F, Olivotto I, Vanni S, et al. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol, 2006, 97: 1386-1390.
|
10. |
Krüger S, Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J, 2004, 147: 60-65.
|
11. |
Tulevski II, ten Wolde M, van Veldhuisen DJ, et al. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol, 2007, 116: 161-166.
|
12. |
Logeart D, Lecuyer L, Thabut G, et al. Biomarker-based strategy for screening right ventricular dysfunction in patients with nonmassive pulmonary embolism. Intensive Care Med, 2007, 33: 286-292.
|
13. |
Ray P, Maziere F, Medimagh S, et al. Evaluation of B-type natriuretic peptide to predict complicated pulmonary embolism in patients aged 65 years and older: brief report. Am J Emerg Med, 2006, 24: 603-607.
|
14. |
杜林林, 邱俏檬, 卢中秋, 等. BNP在急性肺栓塞中的变化及意义. 医学研究杂志, 2007, 36(3): 46-48.
|
15. |
李炳华, 王惠阁, 张金卓, 等. 脑钠肽和肌钙蛋白I联合检测对急性肺栓塞预后评估的意义. 临床医药, 2007, 16(23): 54-55.
|
16. |
Pruszczyk P, Kostrubiec M, Bochowicz A, et al. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J, 2003, 22: 649-653.
|
17. |
Kucher N, Printzen G, Doernhoefer T, et al. Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation, 2003, 107: 1576-1578.
|
18. |
Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J, 2005, 26: 2166-2172.
|
19. |
Binder L, Pieske B, Olschewski M, et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation, 2005, 112: 1573-1579.
|
20. |
Maziere F, Birolleau S, Medimagh S, et al. Comparison of troponin I and N-terminal-pro Btype natriuretic peptide for risk stratification in patients with pulmonary embolism. Eur J Emerg Med, 2007, 14: 207-211.
|
21. |
Alonso-Martínez JL, Urbieta-Echezarreta M, Anniccherico-Sánchez FJ, et al. N-Terminal Pro-B-Type Natriuretic Peptide Predicts the Burden of Pulmonary Embolism. Am J Med Sci, 2009, 337(2): 88-92.
|
22. |
Kostrubiec M, Pruszczyk P, Kaczynska A, et al. Persistent NT-proBNP elevation in acute pulmonary embolism predicts early death. Clin Chim Acta, 2007, 382(1-2): 124-128.
|
23. |
Becattini C, Cristina Vedovati M, et al. Prognostic value of troponins in acute pulmonary embolism. Circulation, 2007, 116: 427-433.
|